[1] Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev,2004,202:8-32.
[2] Hadjadj J, Yatim N, Barnabei L, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.Science, 2020,369(6504):718-724.
[3] Park A, Iwasaki A. Type I and type III interferons - induction, signaling, evasion, and application to combat COVID-19.Cell Host Microbe,2020,27(6):870-878.
[4] Nancy L, Dazhou N, Brissette R, et al. Interferon-α2 variants in the human genome. J Interf Cytok Res,1995,15:341-349.
[5] Antonelli G, Giannelli G, Pistello M,et al. Clinical significance of recombinant interferon-alpha 2 neutralizing antibodies in hepatitis patients.J Interf Res,1994, 14(4):211-213.
[6] Giannelli G, Antonelli G, Fera G, et al. Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-alpha) during therapy for chronic hepatitis C. Clin Exp Immunol,1994,97(1):4-9.
[7] 申昆玲,张国成,尚云晓,等.重组人干扰素α1b在儿科的临床应用专家共识.中华实用儿科临床杂志,2015,30(16):1214-1219.
? Díaz M, Pomykala H M, Bohlander S K, et al. Structure of the human type-I interferon gene cluster determined from a YAC clone contig.Genomics,1994,22(3):540-552.
[8] 黎孟枫,金奇,胡钢,等.一种变异α1型干扰素基因新变种的发现与鉴定.中国科学 B集,1991,4:397-402.
[9] Goeddel DV, Leung DW, Dull TJ,et al. The structure of eight distinct cloned human leukocyte interferon cDNAs. Nature,1981,290(5801):20-26.
[10] Nagata S, Mantei N, Weissmann C. The structure of one of the eight or more distinct chromosomal genes for human interferon-alpha. Nature,1980,287(5781): 401-408.
[11] Streuli M, Nagata M, Weissman C. At least three human type alpha interferons: structure of alpha 2. Science,1980,209:1343–1347.
[12] Goeddel DV, Yelverton E, Ullrich A, et al. Human leukocyte interferon production by E. coli is biologically active. Nature,1980,287:411-416.
[13] Bodo G, Fogy I. Characterization of different molecular species in affinity purified recombinant human interferon α2. In: The Interferon System, Dianzani F, Rossi GB,eds. Serono Symposia Publications, Vol. 24, New York: Raven Press, 1985,23-27.
[14] Chelbi-Alix MK, Wietzerbin J. Interferon, a growing cytokine family: 50 years of interferon research. Biochimie,2007,89(6-7):713-718.
[15] Chen JB, Baig E, Fish EN. Diversity and relatedness among the type I interferons. J Interf Cytok Res,2004,24:687–698.
[16] Herwig P M, Thomas M, Aanna Z, et al. The differential activity of interferon-α subtypes is consistent among distinct target genes and cell types. Cytokine,2011, 53(1): 52-59.
[17] Prokunina-Olsson L. Genetics of the human interferon lambda region. J Interf Cytok Res,2019,39(10):599-608.
[18] 王兵,杨昊欣,杨楠,等.中国健康汉族人基因组DNA中干扰素α1和干扰素α2等位基因组成的测定.生物学杂志,2019,36(5):41-45.
[19] Masakazu K, Tanaka K, Uoshima N, et al. Determination of interferon-al allele composition in the genomic DNA from healthy volunteers and leukemic patients in Japan. J Interf Cytok Res,1997,17:135-140. |